Novel cyclohexane derivatives

Details for Australian Patent Application No. 2005318539 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Wright, Matthew Blake; Panday, Narendra; Kuhn, Bernd; Dehmlow, Henrietta; Masciadri, Raffaello; Ratni, Hasane

Agent Spruson & Ferguson

Pub. Number AU-B-2005318539

PCT Pub. Number WO2006/066779

Priority 04106896.6 22.12.04 EP

Filing date 14 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 8 January 2009

International Classifications

C07C 311/37 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07C 233/23 (2006.01) Carboxylic acid amides

C07D 231/10 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 277/22 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/066779 Priority application(s): WO2006/066779

8 January 2009 Application Accepted

  Published as AU-B-2005318539

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318548-Transdermal plaster with progesterone A-specific ligands (PRASL) as an active ingredient

2005318538-Novel heteroarylacetamides